Waters® Corporation held a groundbreaking ceremony for its new Mass Spectrometry Headquarters planned for completion in 2014.
20 June, 2012
The University of Cambridge is embarking on a programme of scientific open collaboration with GlaxoSmithKline (GSK) that will involve working alongside GSK scientists and other partner organizations, to advance drug discovery and the development of new medicines.
19 June, 2012
On the occasion of World Anti-Counterfeiting Day, EAEPC, EFPIA, GIRP and PGEU are pleased to announce significant progress on their proposed European Stakeholder Model (ESM), a European medicines verification project aimed at preventing falsified medicines from entering the European supply chain and improving patient safety.
13 June, 2012
The Government is too focused on encouraging ‘breakthrough drugs’ at the expense of significant gains for patients from incremental innovation in medicines, warned Stephen Whitehead, Chief Executive of the ABPI. Stephen Whitehead warned that this approach threatens the future of pharmaceutical medical research in the UK.
06 June, 2012
Bristol-Myers Squibb Company today announced the formation of the International Immuno-Oncology Network (II-ON), a global collaboration between industry and academia that aims to further the scientific understanding of immuno-oncology.
01 June, 2012